CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,146,608 | -29.4% | 273,002 | +1.1% | 0.00% | -100.0% |
| Q4 2022 | $1,623,307 | +8.2% | 270,101 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $1,500,000 | +4.2% | 257,696 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $1,439,000 | +717.6% | 241,012 | +542.8% | 0.00% | – |
| Q1 2022 | $176,000 | +89.2% | 37,496 | 0.0% | 0.00% | – |
| Q4 2021 | $93,000 | -16.2% | 37,496 | 0.0% | 0.00% | – |
| Q3 2021 | $111,000 | +122.0% | 37,496 | +87.5% | 0.00% | – |
| Q2 2021 | $50,000 | -15.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2021 | $59,000 | -9.2% | 20,000 | 0.0% | 0.00% | – |
| Q4 2020 | $65,000 | -30.1% | 20,000 | -79.1% | 0.00% | – |
| Q1 2019 | $93,000 | +31.0% | 95,500 | 0.0% | 0.00% | – |
| Q4 2018 | $71,000 | -65.7% | 95,500 | 0.0% | 0.00% | – |
| Q3 2018 | $207,000 | -62.2% | 95,500 | -13.1% | 0.00% | – |
| Q2 2018 | $547,000 | – | 109,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |